Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5750
-0.0050 (-0.86%)
At close: Mar 18, 2026
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 198.65 million as of March 18, 2026. Its market cap has increased by 17.54% in one year.
Market Cap
198.65M
Enterprise Value
184.07M
Revenue
79.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.58
Market Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 198.65M, a decrease of -50.96%. That is a compound annual growth rate of -11.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 200.38M | -21.52% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 826.47M |
| PolyNovo | 659.76M |
| Lumos Diagnostics Holdings | 215.38M |
| EMVision Medical Devices | 148.70M |
| SomnoMed | 138.71M |
| Epiminder | 134.14M |
| Cleo Diagnostics | 64.33M |
| Compumedics | 60.93M |